Clearmind Medicine (CMND) vs Kairos Pharma (KAPA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clearmind Medicine is the larger company by market cap ($3.3 million vs $3.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CMND | KAPA |
|---|---|---|
| Share price | $6.60 | $0.9595 |
| Market cap | $3.35M | $3.25M |
| 1-day change | 0.00% | +10.29% |
| EPS (TTM) | $-461.20 | $-1.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3,840.00 | $9.24 |
| 52-week low | $5.25 | $0.848 |
| Distance from 52-week high | -99.83% | -89.62% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +5006.83% |
| Average volume | 70.89K | 602.89K |
| Shares outstanding | 507.40K | 3.39M |
| Employees | — | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Clearmind Medicine
CMND stock →Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
Healthcare · Biotechnology
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Healthcare · Biotechnology · 1 employees
CMND vs KAPA FAQ
Which is bigger, Clearmind Medicine or Kairos Pharma?
Clearmind Medicine (CMND) is larger, with a market capitalization of $3.35M compared with $3.25M for Kairos Pharma (KAPA).
Are Clearmind Medicine and Kairos Pharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.